Skip to main content
Premium Trial:

Request an Annual Quote

Genescient Teams with Kronos on Alzheimer’s Research

NEW YORK (GenomeWeb News) – Genescient and Kronos Science Laboratory will collaborate to identify genes that may be involved in Alzheimer’s disease, Genescient said today.

The company said it hopes to use Kronos’ Alzheimer's disease data set to target genes that previously have not been recognized as linked to the disease.

Irvine, Calif.-based Genescient said it has identified over 750 unique human genomic pathways that may be associated with age-related diseases such as cardiovascular disease, type II diabetes, and other chronic diseases. The company said its technology enables scientists to “probe the entire biochemical machinery behind chronic diseases.”

Financial and other terms of the collaboration were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.